Fig. 2
Cell cycle distribution of MCF-7 cells treated with thonningiol (9), seputhecarpan D (13) and doxorubicin for 72 h. IC50: 0.36 μM (thonningiol), 9.78 μM (seputhecarpan D) and 0.35 μM (doxorubicin)
Fig. 2 | BMC Complementary and Alternative Medicine